Allianz Asset Management GmbH - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 52 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2022$52,188,000
+21.9%
52,500,000
+22.1%
0.05%
+56.2%
Q1 2022$42,825,000
-23.0%
43,000,000
-20.6%
0.03%
-40.7%
Q1 2021$55,622,000
+68.8%
54,180,000
+76.3%
0.05%
+63.6%
Q4 2020$32,949,000
+15.7%
30,730,000
+12.9%
0.03%0.0%
Q3 2020$28,480,000
-52.5%
27,230,000
-44.6%
0.03%
-52.2%
Q2 2020$60,002,000
+155.5%
49,150,000
+118.4%
0.07%
+122.6%
Q1 2020$23,485,000
-60.6%
22,500,000
-62.7%
0.03%
-47.5%
Q3 2019$59,538,000
-20.3%
60,355,000
-16.1%
0.06%
-14.5%
Q2 2019$74,677,000
+12.9%
71,905,000
+11.2%
0.07%
+4.5%
Q1 2019$66,119,000
-18.8%
64,645,000
-21.2%
0.07%
-25.8%
Q4 2018$81,392,000
+3.5%
82,000,000
+11.3%
0.09%
+25.4%
Q3 2018$78,643,000
+38.0%
73,705,000
+31.2%
0.07%
+29.1%
Q2 2018$56,992,000
+54.4%
56,180,000
+43.4%
0.06%
+57.1%
Q1 2018$36,908,000
-11.4%
39,180,000
-6.2%
0.04%
+6.1%
Q4 2017$41,671,000
+50.9%
41,755,000
+53.5%
0.03%
+37.5%
Q3 2017$27,608,00027,200,0000.02%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q4 2020
NameSharesValueWeighting ↓
SHENKMAN CAPITAL MANAGEMENT INC 30,138,000$29,510,0003.72%
PFM Health Sciences, LP 45,910,000$46,002,0001.72%
Cheyne Capital Management (UK) LLP 2,320,000$2,330,0001.47%
ADVENT CAPITAL MANAGEMENT /DE/ 41,077,000$41,277,0000.66%
SSI INVESTMENT MANAGEMENT LLC 9,071,000$9,068,0000.50%
PALISADE CAPITAL MANAGEMENT, LP 14,548,000$14,612,0000.34%
RWC Asset Management LLP 7,500,000$7,552,0000.21%
KBC Group NV 400,000$40,316,0000.15%
PROSPECTOR PARTNERS LLC 1,000,000$1,000,0000.12%
MACKAY SHIELDS LLC 11,822,000$11,816,0000.10%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders